Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Basic Body Awareness Therapy for Healthy Young Adults

11. června 2026 aktualizováno: Özge ÇANKAYA

An Investigation Into the Effects of Basic Body Awareness Therapy on Musculoskeletal Pain, Spinal Mobility, Balance and Flexibility

Background:

Musculoskeletal pain, impaired postural control, and reduced movement quality are increasingly observed among young adults, partly due to sedentary lifestyles and insufficient physical activity. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach designed to enhance body awareness, movement quality, balance, and postural stability through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.

Objective:This study aims to investigate the effects of a 12-week BBAT program on balance, musculoskeletal pain, spinal mobility, and flexibility in healthy young adults.

Methods:This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through voluntary participation and social media announcements. Participants will be randomly assigned to either a BBAT intervention group or a control group. The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes, while the control group will receive no intervention. Eligible participants will be individuals aged 18-40 years who have not participated in structured body-awareness-based exercise programs, such as BBAT, yoga, or Pilates, within the previous six months and who are able to complete all assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medication use affecting balance will be excluded.

Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.

Přehled studie

Postavení

Zatím nenabíráme

Podmínky

Intervence / Léčba

Detailní popis

Background:

Musculoskeletal pain, postural control impairments, and reduced movement quality are increasingly prevalent among young adults, partly due to sedentary lifestyles and low physical activity levels. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach that aims to improve body awareness, postural stability, movement quality, and balance through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.

Objective:

This study aims to investigate the effects of a 12-week BBAT program on musculoskeletal pain, spinal mobility, balance, and flexibility in healthy young adults.

Methods:

This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through social media announcements and voluntary participation. Participants will be randomly allocated to either an intervention group or a control group.

The intervention group will participate in BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes. The control group will receive no intervention during the study period. Inclusion criteria include being 18-40 years old, not having participated in structured body-awareness-based programs (e.g., BBAT, yoga, or Pilates) within the previous six months, and being able to complete the assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medications affecting balance will be excluded.

Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.

Sample size estimation was conducted using G*Power 3.1 based on a medium effect size (f = 0.25), α = 0.05, power = 80%, two groups, and two measurement points. The minimum required sample size was calculated as 36 participants. Considering a potential dropout rate of 15-20%, at least 40 participants (20 per group) will be recruited.

Hypotheses:

Compared with the control group, participants receiving BBAT are expected to demonstrate significantly greater improvements in (1) spinal mobility , (2) flexibility , (3)musculoskeletal pain, and (4) balance outcomes.

Typ studie

Intervenční

Zápis (Odhadovaný)

40

Fáze

  • Nelze použít

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dospělý

Přijímá zdravé dobrovolníky

Ano

Popis

Inclusion Criteria:

  • Age between 18 and 40 years.
  • Ability to walk independently without assistive devices.
  • No participation in structured body-awareness-based exercise programs (e.g., Basic Body Awareness Therapy, yoga, or Pilates) within the previous 6 months.
  • Ability to understand study procedures and comply with assessment protocols.
  • Willingness to participate and provision of written informed consent.

Exclusion Criteria:

  • History of neurological, vestibular, rheumatologic, or severe orthopedic disorders that may affect movement, balance, or mobility.
  • History of spinal or lower-extremity surgery or musculoskeletal injury within the previous 6 months.
  • Severe musculoskeletal pain limiting participation in assessments or intervention sessions.
  • Pregnancy.
  • Current use of medications known to affect balance, postural control, or motor performance.
  • Presence of acute infection or other acute medical conditions at the time of enrollment.

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Podpůrná péče
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Žádný zásah: Control
The control group will be assessed for spinal mobility, flexibility, musculoskeletal pain, and balance at baseline and following a 12-week follow-up period. Participants in this group will not receive any intervention throughout the study.
Experimentální: Exercise

The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes.

BBAT exercises include; Grounding Postural balance Co-ordination Breathing Flow Mental awareness
Jiný: Exercise

Participants allocated to the intervention group will receive a 12-week Basic Body Awareness Therapy (BBAT) program. The intervention will be delivered once weekly on the same day and at the same time each week, with each session lasting approximately 45-60 minutes.

The BBAT program will consist of structured exercises performed in supine, sitting, and standing positions, focusing on postural alignment, muscle activation and relaxation, breathing awareness, weight transfer, balance control, and movement quality. Individual and partner-based exercises will be used to enhance body awareness, postural stability, and coordinated movement patterns.

All sessions will be supervised and conducted by a physiotherapist who has completed BBAT Level III training. Participants will be encouraged to perform the movements with attention to body awareness, balance, breathing, and movement efficiency throughout the intervention period.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Spinal mobility
Časové okno: Baseline and Week 12
Spinal mobility will be assessed using the Spinal Mouse® system (Idiag AG, Fehraltorf, Switzerland). Measurements will be obtained in neutral standing, maximal flexion, maximal extension, and maximal lateral flexion positions. Two measurements will be recorded for each position, and the average value will be used for analysis.
Baseline and Week 12
Flexibility
Časové okno: Baseline and Week 12
Flexibility of the lumbar region and lower extremities will be evaluated using the Sit-and-Reach Test. Participants will perform three trials, and the best score (cm) will be recorded for analysis.
Baseline and Week 12

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Musculoskeletal pain
Časové okno: Baseline and Week 12
Musculoskeletal pain and discomfort will be assessed using the Cornell Musculoskeletal Discomfort Questionnaire (CMDQ). The CMDQ evaluates the frequency, severity, and functional impact of discomfort in different body regions. Total CMDQ scores will be used for analysis.
Baseline and Week 12
Balance
Časové okno: Baseline and Week 12
Balance performance will be assessed using the HUR Balance® system. Static and dynamic postural control parameters, including center-of-pressure sway and stability measures, will be recorded according to the standardized testing protocol.
Baseline and Week 12

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Sponzor

Özge ÇANKAYA

Spolupracovníci

Saglik Bilimleri Universitesi

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

15. června 2026

Primární dokončení (Odhadovaný)

15. září 2026

Dokončení studie (Odhadovaný)

15. května 2027

Termíny zápisu do studia

První předloženo

8. června 2026

První předloženo, které splnilo kritéria kontroly kvality

11. června 2026

První zveřejněno (Aktuální)

16. června 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

16. června 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

11. června 2026

Naposledy ověřeno

1. června 2026

Více informací

Termíny související s touto studií

Klíčová slova

Další relevantní podmínky MeSH

Další identifikační čísla studie

  • SBUBBAT

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NEROZHODNÝ

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Klinické studie na Mladí zdraví dospělí

Prohledejte podobné pokusy

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

CROs by country

CROs in Taiwan

Podmínky

Vzácné nemoci

Drogové intervence

Doplňky stravy

Sponzor / Spolupracovníci

Místa

Předplatit